BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malouff TD, Peterson JL, Mahajan A, Trifiletti DM. Carbon ion radiotherapy in the treatment of gliomas: a review. J Neurooncol 2019;145:191-9. [DOI: 10.1007/s11060-019-03303-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Bennan ABA, Unkelbach J, Wahl N, Salome P, Bangert M. Joint Optimization of Photon-Carbon Ion Treatments for Glioblastoma. Int J Radiat Oncol Biol Phys 2021;111:559-72. [PMID: 34058258 DOI: 10.1016/j.ijrobp.2021.05.126] [Reference Citation Analysis]
2 Hutóczki G, Virga J, Birkó Z, Klekner A. Novel Concepts of Glioblastoma Therapy Concerning Its Heterogeneity. Int J Mol Sci 2021;22:10005. [PMID: 34576168 DOI: 10.3390/ijms221810005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, Rudà R, Short S, Smits M, Taphoorn MJB, von Deimling A, Westphal M, Soffietti R, Reifenberger G, Wick W. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 2021;18:170-86. [PMID: 33293629 DOI: 10.1038/s41571-020-00447-z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 32.0] [Reference Citation Analysis]
4 Liu EK, Sulman EP, Wen PY, Kurz SC. Novel Therapies for Glioblastoma. Curr Neurol Neurosci Rep 2020;20:19. [PMID: 32445058 DOI: 10.1007/s11910-020-01042-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
5 Palma A, Grande S, Ricci-Vitiani L, Luciani AM, Buccarelli M, Biffoni M, Dini V, Cirrone GAP, Ciocca M, Guidoni L, Pallini R, Viti V, Rosi A. Different Mechanisms Underlie the Metabolic Response of GBM Stem-Like Cells to Ionizing Radiation: Biological and MRS Studies on Effects of Photons and Carbon Ions. Int J Mol Sci 2020;21:E5167. [PMID: 32708312 DOI: 10.3390/ijms21145167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wang H, Chen W, Wu G, Kong J, Yuan S, Chen L. A Magnetic T7 Peptide&AS1411 Aptamer-Modified Microemulsion for Triple Glioma-Targeted Delivery of Shikonin and Docetaxel. J Pharm Sci 2021;110:2946-54. [PMID: 33785350 DOI: 10.1016/j.xphs.2021.03.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Xie Y, Han Y, Zhang X, Ma H, Li L, Yu R, Liu H. Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma. Front Oncol 2021;11:633827. [PMID: 33869019 DOI: 10.3389/fonc.2021.633827] [Reference Citation Analysis]
8 Venkatesulu BP, Giridhar P, Malouf TD, Trifletti DM, Krishnan S. A systematic review of the role of carbon ion radiation therapy in recurrent rectal cancer. Acta Oncol 2020;59:1218-23. [PMID: 32476538 DOI: 10.1080/0284186X.2020.1769184] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Galanis E, Wen PY, de Groot JF, Weller M. Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma. Hematol Oncol Clin North Am 2022;36:113-32. [PMID: 34756799 DOI: 10.1016/j.hoc.2021.08.007] [Reference Citation Analysis]
10 Nordmann NJ, Michael AP. 5-Aminolevulinic acid radiodynamic therapy for treatment of high-grade gliomas: A systematic review. Clin Neurol Neurosurg 2021;201:106430. [PMID: 33360951 DOI: 10.1016/j.clineuro.2020.106430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Li Y, Deng G, Qi Y, Zhang H, Gao L, Jiang H, Ye Z, Liu B, Chen Q. Bioinformatic Profiling of Prognosis-Related Genes in Malignant Glioma Microenvironment. Med Sci Monit 2020;26:e924054. [PMID: 32843610 DOI: 10.12659/MSM.924054] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kast RE, Michael AP, Sardi I, Burns TC, Heiland T, Karpel-Massler G, Kamar FG, Halatsch ME. A New Treatment Opportunity for DIPG and Diffuse Midline Gliomas: 5-ALA Augmented Irradiation, the 5aai Regimen. Brain Sci 2020;10:E51. [PMID: 31963414 DOI: 10.3390/brainsci10010051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shirvalilou S, Khoei S, Esfahani AJ, Kamali M, Shirvaliloo M, Sheervalilou R, Mirzaghavami P. Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review. J Neurooncol 2021;152:419-28. [PMID: 33713248 DOI: 10.1007/s11060-021-03729-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Frosina G. Improving control of high‐grade glioma by ultra‐hyper‐fractionated radiotherapy. J of Neuroscience Research. [DOI: 10.1002/jnr.25030] [Reference Citation Analysis]
15 Ma Q, Yang T. E2F transcription factor 1/small nucleolar RNA host gene 18/microRNA-338-5p/forkhead box D1: an important regulatory axis in glioma progression. Bioengineered 2022;13:418-30. [PMID: 34937497 DOI: 10.1080/21655979.2021.2005990] [Reference Citation Analysis]
16 Ebner DK, Frank SJ, Inaniwa T, Yamada S, Shirai T. The Emerging Potential of Multi-Ion Radiotherapy. Front Oncol 2021;11:624786. [PMID: 33692957 DOI: 10.3389/fonc.2021.624786] [Reference Citation Analysis]